V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20029850 | 20012724 | 1.72 | 78.9 | Adjuvant (A) | null | 2015-09-24 | FEC + DOCETAXEL | N | N | 20105176 | FEC + DOCETAXEL |
| 20029851 | 20012724 | 1.71 | 61 | Adjuvant (A) | 2016-01-14 | 2016-01-26 | FEC + DOCETAXEL | 2 | N | 20105176 | FEC + DOCETAXEL |
| 20029852 | 20012724 | 1.57 | 69.3 | Adjuvant (A) | 2017-10-19 | 2017-11-09 | FEC 60 OR 75 + DOCETAXEL | N | N | 20105176 | FEC + DOCETAXEL |
| 20029853 | 20012725 | null | null | Neo-adjuvant (N) | 2016-11-29 | 2016-12-22 | FEC + DOCETAXEL | N | N | 20105195 | FEC + DOCETAXEL |
| 20029854 | 20012725 | 1.6 | 65.6 | Adjuvant (A) | 2013-03-25 | 2013-04-22 | FEC 60 OR 75 + DOCETAXEL | N | N | 20105195 | FEC + DOCETAXEL |
| 20029855 | 20012726 | 1.59 | 67.9 | Adjuvant (A) | 2015-03-25 | 2015-04-15 | FEC 100 + DOCETAXEL | N | N | 20105199 | FEC + DOCETAXEL |
| 20029856 | 20012726 | 1.66 | 49 | Adjuvant (A) | 2017-08-02 | 2017-08-18 | FEC + DOCETAXEL | 02 | N | 20105199 | FEC + DOCETAXEL |
| 20029857 | 20012727 | 1.52 | 101 | null | 2016-05-12 | 2016-05-12 | FEC + DOCETAXEL | 02 | N | 20105204 | FEC + DOCETAXEL |
| 20029858 | 20012727 | 1.66 | 61.2 | Adjuvant (A) | null | 2015-09-07 | FEC + DOCETAXEL | N | N | 20105204 | FEC + DOCETAXEL |
| 20029859 | 20109206 | 1.6 | 88.5 | Neo-adjuvant (N) | 2017-05-22 | 2017-06-07 | FEC 100 + DOCETAXEL | 2 | N | 20105225 | FEC + DOCETAXEL |
| 20029860 | 20109206 | null | 53.3 | Adjuvant (A) | 2013-10-06 | 2013-11-12 | FEC 100 + DOCETAXEL | N | N | 20105225 | FEC + DOCETAXEL |
| 20029861 | 20012728 | 1.72 | 92 | Curative (C) | null | 2014-04-11 | FEC 100 + DOCETAXEL | N | N | 20105230 | FEC + DOCETAXEL |
| 20029862 | 20012728 | null | 61.8 | Adjuvant (A) | 2017-06-13 | 2017-06-14 | FEC + DOCETAXEL | N | N | 20105230 | FEC + DOCETAXEL |
| 20029863 | 20012729 | 1.62 | null | null | 2015-10-10 | 2015-10-18 | FEC + DOCETAXEL | N | null | 20105236 | FEC + DOCETAXEL |
| 20029864 | 20012729 | 1.58 | null | Adjuvant (A) | 2016-10-13 | 2016-10-27 | FEC + DOCETAXEL | N | N | 20105236 | FEC + DOCETAXEL |
| 20029865 | 20012730 | null | 65.8 | Adjuvant (A) | 2013-08-03 | 2013-08-05 | FEC + DOCETAXEL | N | N | 20105259 | FEC + DOCETAXEL |
| 20029866 | 20012730 | 1.73 | 73.6 | Adjuvant (A) | null | 2013-06-11 | FEC + DOCETAXEL | N | N | 20105259 | FEC + DOCETAXEL |
| 20029867 | 20012731 | 1.56 | 53.4 | Not known (9) | 2018-02-07 | 2018-02-22 | FEC + DOCETAXEL | 02 | N | 20105276 | FEC + DOCETAXEL |
| 20029868 | 20012731 | 1.55 | 77.6 | Adjuvant (A) | 2017-11-16 | 2018-01-17 | FEC + DOCETAXEL | N | N | 20105276 | FEC + DOCETAXEL |
| 20029869 | 20012732 | null | null | Adjuvant (A) | 2015-11-13 | 2015-11-27 | FEC 100 + DOCETAXEL | null | null | 20105280 | FEC + DOCETAXEL |
| 20029870 | 20012732 | null | null | Adjuvant (A) | 2015-01-13 | 2015-01-18 | FEC + DOCETAXEL | N | N | 20105280 | FEC + DOCETAXEL |
| 20029871 | 20012732 | 1.61 | 86.5 | Neo-adjuvant (N) | 2014-09-13 | 2014-09-22 | FEC + DOCETAXEL | 02 | null | 20105280 | FEC + DOCETAXEL |
| 20029872 | 20012733 | 1.63 | 92.2 | Neo-adjuvant (N) | 2015-09-13 | 2015-10-03 | FEC 100 + DOCETAXEL | N | N | 20105285 | FEC + DOCETAXEL |
| 20029873 | 20012733 | 1.5 | 63.4 | Adjuvant (A) | 2015-05-14 | 2015-05-28 | FEC + DOCETAXEL | N | N | 20105285 | FEC + DOCETAXEL |
| 20029874 | 20012734 | 1.65 | 77.5 | Neo-adjuvant (N) | 2013-01-27 | 2013-01-27 | FEC 100 + DOCETAXEL | 02 | null | 20105288 | FEC + DOCETAXEL |
| 20029875 | 20012734 | 1.61 | 63 | Neo-adjuvant (N) | 2014-08-05 | 2014-08-26 | FEC + DOCETAXEL | 02 | null | 20105288 | FEC + DOCETAXEL |
| 20029876 | 20012735 | 1.59 | 61 | Adjuvant (A) | 2016-02-19 | 2016-03-01 | FEC 100 + DOCETAXEL | 2 | N | 20105291 | FEC + DOCETAXEL |
| 20029877 | 20012735 | 1.64 | 65.45 | Adjuvant (A) | 2014-07-02 | 2014-07-08 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20105291 | FEC + DOCETAXEL |
| 20029878 | 20012736 | null | null | Neo-adjuvant (N) | null | 2013-10-05 | FEC + DOCETAXEL | null | null | 20105300 | FEC + DOCETAXEL |
| 20029879 | 20012736 | null | null | null | null | 2017-01-06 | FEC + DOCETAXEL | null | null | 20105300 | FEC + DOCETAXEL |
| 20029880 | 20012737 | 1.55 | 61.3 | Adjuvant (A) | null | 2015-02-22 | FEC 100 + DOCETAXEL | N | N | 20105303 | FEC + DOCETAXEL |
| 20029881 | 20012737 | 1.64 | 70.7 | Not known (9) | 2015-02-11 | 2015-02-19 | FEC 100 + DOCETAXEL | 02 | N | 20105303 | FEC + DOCETAXEL |
| 20029882 | 20012737 | 1.62 | 75 | Adjuvant (A) | 2016-08-09 | 2016-08-22 | FEC + DOCETAXEL | 02 | N | 20105303 | FEC + DOCETAXEL |
| 20029883 | 20012738 | 1.52 | 90.3 | Adjuvant (A) | 2016-04-19 | 2016-08-02 | FEC + DOCETAXEL | N | N | 20105310 | FEC + DOCETAXEL |
| 20029884 | 20012738 | 1.7 | 60.9 | Adjuvant (A) | 2018-01-25 | 2018-01-25 | FEC 100 + DOCETAXEL | 02 | N | 20105310 | FEC + DOCETAXEL |
| 20029885 | 20012738 | 1.63 | 62.4 | Neo-adjuvant (N) | 2017-05-20 | 2017-05-20 | FEC + DOCETAXEL | 02 | N | 20105310 | FEC + DOCETAXEL |
| 20029886 | 20012739 | 1.7 | null | Adjuvant (A) | 2015-09-29 | 2015-10-11 | FEC 100 + DOCETAXEL | N | N | 20105317 | FEC + DOCETAXEL |
| 20029887 | 20012739 | 1.67 | 70.5 | Adjuvant (A) | 2013-07-05 | 2013-07-08 | FEC + DOCETAXEL | 02 | N | 20105317 | FEC + DOCETAXEL |
| 20029888 | 20012740 | null | null | null | 2015-12-07 | 2015-12-20 | FEC + DOCETAXEL | N | N | 20105322 | FEC + DOCETAXEL |
| 20029889 | 20012740 | 1.64 | 93 | Adjuvant (A) | 2015-08-07 | 2015-08-20 | FEC + DOCETAXEL | 2 | N | 20105322 | FEC + DOCETAXEL |
| 20029890 | 20012740 | 1.66 | 71 | Neo-adjuvant (N) | 2015-02-23 | 2015-03-15 | FEC + DOCETAXEL | 02 | N | 20105322 | FEC + DOCETAXEL |
| 20029891 | 20012740 | 1.66 | 63.4 | Adjuvant (A) | 2015-03-15 | 2015-03-26 | FEC 100 + DOCETAXEL | N | N | 20105322 | FEC + DOCETAXEL |
| 20029892 | 20012740 | 1.78 | 81 | Adjuvant (A) | 2013-06-17 | 2013-07-13 | FEC + DOCETAXEL | N | N | 20105322 | FEC + DOCETAXEL |
| 20029893 | 20012740 | 1.8 | 66 | Palliative (P) | 2015-06-27 | 2015-07-15 | FEC + DOCETAXEL | 2 | N | 20105322 | FEC + DOCETAXEL |
| 20029894 | 20012741 | 1.56 | 72 | Adjuvant (A) | 2014-10-07 | 2014-10-22 | FEC 100 + DOCETAXEL | N | N | 20105335 | FEC + DOCETAXEL |
| 20029895 | 20012741 | 1.67 | 105.8 | Adjuvant (A) | 2017-04-19 | 2017-04-19 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20105335 | FEC + DOCETAXEL |
| 20029896 | 20012741 | 1.53 | 64.6 | Neo-adjuvant (N) | 2017-03-01 | 2017-03-22 | FEC + DOCETAXEL | 02 | N | 20105335 | FEC + DOCETAXEL |
| 20029897 | 20012742 | 1.68 | 81 | Adjuvant (A) | 2013-10-28 | 2013-11-13 | FEC 100 + DOCETAXEL | N | N | 20105339 | FEC + DOCETAXEL |
| 20029898 | 20012742 | 1.64 | 102.9 | Neo-adjuvant (N) | 2013-07-04 | 2013-07-04 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20105339 | FEC + DOCETAXEL |
| 20029899 | 20012742 | null | 58 | Neo-adjuvant (N) | 2015-03-04 | 2015-03-09 | FEC 100 + DOCETAXEL | N | null | 20105339 | FEC + DOCETAXEL |